Autoimmune encephalitis: Recent updates and emerging challenges

Journal of Clinical Neuroscience

Volumn 21, Issue 5, 2014, Pages 722-730

  Ramanathan, Sudarshini ^a,b   Mohammad, Shekeeb S ^a,c   Brilot, Fabienne ^a   Dale, Russell C ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Anti NMDAR encephalitis; Autoimmune encephalitis; Autoimmune epilepsy; Basal ganglia encephalitis; Limbic encephalitis; VGKC encephalitis

Indexed keywords

AUTOANTIBODY;

ANIMAL; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; BRAIN DISEASES; CASE REPORT; CHILD; FEMALE; HASHIMOTO DISEASE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; MALE; PRESCHOOL CHILD; TRENDS;

ANIMALS; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HASHIMOTO DISEASE; HUMANS; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; MALE;

EID: 84898599207     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.07.017     Document Type: Review

References (96)

1. A. Vincent, C. Buckley, and J.M. Schott et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis Brain 127 2004 701 712
2. F. Graus, A. Saiz, and J. Dalmau Antibodies and neuronal autoimmune disorders of the CNS J Neurol 257 2010 509 517
3. E. Lancaster, E. Martinez-Hernandez, and J. Dalmau Encephalitis and antibodies to synaptic and neuronal cell surface proteins Neurology 77 2011 179 189
4. C.G. Bien, A. Vincent, and M.H. Barnett et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis Brain 135 2012 1622 1638
5. L. Zuliani, F. Graus, and B. Giometto et al. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition J Neurol Neurosurg Psychiatry 83 2012 638 645
6. B.M. Ances, R. Vitaliani, and R.A. Taylor et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates Brain 128 2005 1764 1777
7. S.R. Samarasekera, A. Vincent, and J.L. Welch et al. Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies J Neurol Neurosurg Psychiatry 78 2007 391 394
8. E.G. Hughes, X. Peng, and A.J. Gleichman et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis J Neurosci 30 2010 5866 5875
9. E. Lancaster, M. Lai, and X. Peng et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen Lancet Neurol 9 2010 67 76
10. M.R. Rosenfeld, and J. Dalmau Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders Curr Treat Options Neurol 13 2011 324 332
11. E. Lancaster, and J. Dalmau Neuronal autoantigens-pathogenesis, associated disorders and antibody testing Nat Rev Neurol 8 2012 380 390
12. M.P. Malter, C. Helmstaedter, and H. Urbach et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis Ann Neurol 67 2010 470 478
13. S. Vernino, and V.A. Lennon Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability Muscle Nerve 26 2002 702 707
14. K.M. Tan, V.A. Lennon, and C.J. Klein et al. Clinical spectrum of voltage-gated potassium channel autoimmunity Neurology 70 2008 1883 1890
15. J.R. Cornelius, S.J. Pittock, and A. McKeon et al. Sleep manifestations of voltage-gated potassium channel complex autoimmunity Arch Neurol 68 2011 733 738
16. S.R. Irani, S. Alexander, and P. Waters et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Brain 133 2010 2734 2748
17. C. Buckley, J. Oger, and L. Clover et al. Potassium channel antibodies in two patients with reversible limbic encephalitis Ann Neurol 50 2001 73 78
18. P. Pozo-Rosich, L. Clover, and A. Saiz et al. Voltage-gated potassium channel antibodies in limbic encephalitis Ann Neurol 54 2003 530 533
19. S. Jarius, L. Hoffmann, and L. Clover et al. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis J Neurol Sci 268 2008 74 77
20. C.G. Bien Limbic encephalitis: extension of the diagnostic armamentarium J Neurol Neurosurg Psychiatry 78 2007 332 333
21. T. Ohshita, H. Kawakami, and H. Maruyama et al. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma J Neurol Sci 250 2006 167 169
22. S. Jarius, L.A. Hoffmann, and O. Stich et al. Relative frequency of VGKC and 'classical' paraneoplastic antibodies in patients with limbic encephalitis J Neurol 255 2008 1100 1101
23. G.K. Tofaris, S.R. Irani, and B.J. Cheeran et al. Immunotherapy- responsive chorea as the presenting feature of LGI1-antibody encephalitis Neurology 79 2012 195 196
24. C.J. Klein, V.A. Lennon, and P.A. Aston et al. Chronic pain as a manifestation of potassium channel-complex autoimmunity Neurology 79 2012 1136 1144
25. H.J. Majoie, M. de Baets, and W. Renier et al. Antibodies to voltage-gated potassium and calcium channels in epilepsy Epilepsy Res 71 2006 135 141
26. H. Takahashi, M. Mori, and Y. Sekiguchi et al. Development of Isaacs' syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis J Neurol Sci 275 2008 185 187
27. M. Lai, M.G. Huijbers, and E. Lancaster et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series Lancet Neurol 9 2010 776 785
28. S.R. Irani, A.W. Michell, and B. Lang et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis Ann Neurol 69 2011 892 900
29. P. Striano Faciobrachial dystonic attacks: seizures or movement disorder? Ann Neurol 70 2011 179 180
30. A. Vincent, and S.R. Irani Caspr2 antibodies in patients with thymomas J Thorac Oncol 5 2010 S277 S280
31. E.B. Becker, L. Zuliani, and R. Pettingill et al. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia J Neurol Neurosurg Psychiatry 83 2012 437 440
32. E. Lancaster, M.G. Huijbers, and V. Bar et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia Ann Neurol 69 2011 303 311
33. S.R. Irani, P. Pettingill, and K.A. Kleopa et al. Morvan syndrome: clinical and serological observations in 29 cases Ann Neurol 72 2012 241 255
34. L.M. Hartley, S.Y. Ng, and R.C. Dale et al. Immune mediated chorea encephalopathy syndrome in childhood Dev Med Child Neurol 44 2002 273 277
35. R.C. Dale, A.J. Church, and R.A. Surtees et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity Brain 127 2004 21 33
36. R.C. Dale, S.R. Irani, and F. Brilot et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica Ann Neurol 66 2009 704 709
37. G. Sebire, D. Devictor, and G. Huault et al. Coma associated with intense bursts of abnormal movements and long-lasting cognitive disturbances: an acute encephalopathy of obscure origin J Pediatr 121 1992 845 851
38. J. Dalmau, E. Tuzun, and H.Y. Wu et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma Ann Neurol 61 2007 25 36
39. J. Dalmau, A.J. Gleichman, and E.G. Hughes et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies Lancet Neurol 7 2008 1091 1098
40. S.R. Irani, K. Bera, and P. Waters et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes Brain 133 2010 1655 1667
41. T.J. Kleinig, P.D. Thompson, and W. Matar et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis Mov Disord 23 2008 1256 1261
42. T. Iizuka, F. Sakai, and T. Ide et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal Neurology 70 2008 504 511
43. J.H. Smith, R. Dhamija, and B.D. Moseley et al. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis Arch Neurol 68 2011 1069 1072
44. J. Dalmau, E. Lancaster, and E. Martinez-Hernandez et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis Lancet Neurol 10 2011 63 74
45. D.K. Reid, and S.L. Clardy Neurological picture. Anti-NMDA-receptor encephalitis: unusual presentation of an uncommon condition J Neurol Neurosurg Psychiatry 84 2013 69 70
46. M.J. Titulaer, L. McCracken, and I. Gabilondo et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study Lancet Neurol 12 2013 157 165
47. H. Pruss, J. Dalmau, and L. Harms et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin Neurology 75 2010 1735 1739
48. M.S. Gable, H. Sheriff, and J. Dalmau et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project Clin Infect Dis 54 2012 899 904
49. M.E. Novillo-Lopez, J.E. Rossi, and J. Dalmau et al. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man Neurology 70 2008 728 729
50. A. Eker, E. Saka, and J. Dalmau et al. Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis J Neurol Neurosurg Psychiatry 79 2008 1082 1083
51. S.R. Irani, and A. Vincent NMDA receptor antibody encephalitis Curr Neurol Neurosci Rep 11 2011 298 304
52. M.S. Zandi, S.R. Irani, and G. Follows et al. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma Neurology 73 2009 2039 2040
53. C. Poloni, C.M. Korff, and V. Ricotti et al. Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-D-aspartate receptor encephalitis Dev Med Child Neurol 52 2010 e78 e82
54. N.R. Florance, R.L. Davis, and C. Lam et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents Ann Neurol 66 2009 11 18
55. T. Armangue, M.J. Titulaer, and I. Malaga et al. Pediatric Anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients J Pediatr 162 2013 850 856
56. S.C. Pillai, D. Gill, and R. Webster et al. Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis Pediatr Neurol 43 2010 217 220
57. E. Tuzun, L. Zhou, and J.M. Baehring et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma Acta Neuropathol 118 2009 737 743
58. L. Mikasova, P. De Rossi, and D. Bouchet et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis Brain 135 2012 1606 1621
59. A.J. Gleichman, L.A. Spruce, and J. Dalmau et al. Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain J Neurosci 32 2012 11082 11094
60. C. Finke, U.A. Kopp, and H. Pruss et al. Cognitive deficits following anti-NMDA receptor encephalitis J Neurol Neurosurg Psychiatry 83 2012 195 198
61. A.J. Houtrow, M. Bhandal, and N.R. Pratini et al. The rehabilitation of children with anti-N-methyl-D-aspartate-receptor encephalitis: a case series Am J Phys Med Rehabil 91 2012 435 441
62. I. Gabilondo, A. Saiz, and L. Galan et al. Analysis of relapses in anti-NMDAR encephalitis Neurology 77 2011 996 999
63. S. Ramanathan, C. Wong, and V. Fung Long duration between presentation of probable anti-N-methyl-D-aspartate receptor encephalitis and either clinical relapse or positive serum autoantibodies J Clin Neurosci 20 2013 1322 1323
64. H.C. Hansen, C. Klingbeil, and J. Dalmau et al. Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis JAMA Neurol 70 2013 117 119
65. R. Lopez-Alberola, M. Georgiou, and G.N. Sfakianakis et al. Contemporary encephalitis lethargica: phenotype, laboratory findings and treatment outcomes J Neurol 256 2009 396 404
66. R.C. Dale, V. Merheb, and S. Pillai et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders Brain 135 2012 3453 3468
67. A. Uzawa, M. Mori, and Y. Takahashi et al. Anti-N-methyl D-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis Clin Neurol Neurosurg 114 2012 402 404
68. K. Fujita, T. Yuasa, and Y. Takahashi et al. Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients J Neuroimmunol 251 2012 90 93
69. M.C. Kruer, T.K. Koch, and D.N. Bourdette et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica Neurology 74 2010 1473 1475
70. V.K. Nwosu, J.A. Royer, and D.E. Stickler Voltage gated potassium channel antibodies in amyotrophic lateral sclerosis Amyotroph Lateral Scler 11 2010 392 394
71. E. Tuzun, M. Kurtuncu, and B. Lang et al. Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies Eur J Neurol 17 2010 1304 1307
72. J.J. Lin, K.L. Lin, and S.H. Hsia et al. VGKC complex antibodies in pediatric severe acute encephalitis: a study and literature review Brain Dev 35 2013 630 635
73. H.L. Pellkofer, T. Kuempfel, and L. Jacobson et al. Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies J Neurol Neurosurg Psychiatry 81 2010 1407 1408
74. M.R. Turner, S.R. Irani, and M.I. Leite et al. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies Neurology 77 2011 439 443
75. H. Verhelst, P. Verloo, and K. Dhondt et al. Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster Eur J Paediatr Neurol 15 2011 163 166
76. M.S. Gable, S. Gavali, and A. Radner et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis Eur J Clin Microbiol Infect Dis 28 2009 1421 1429
77. Y. Hacohen, S. Wright, and P. Waters et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens J Neurol Neurosurg Psych 84 2013 748 755
78. C.L. Xu, L. Liu, and W.Q. Zhao et al. Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up BMC Neurol 11 2011 149
79. E. Martinez-Hernandez, J. Horvath, and Y. Shiloh-Malawsky et al. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis Neurology 77 2011 589 593
80. H.E. Peery, G.S. Day, and S. Dunn et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology Autoimmun Rev 11 2012 863 872
81. M.P. Malter, C.E. Elger, and R. Surges Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis Seizure 22 2013 136 140
82. A.J. Sinclair, L. Wienholt, and E. Tantsis et al. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology Dev Med Child Neurol 55 2013 71 75
83. J. Suleiman, F. Brilot, and B. Lang et al. Autoimmune epilepsy in children: case series and proposed guidelines for identification Epilepsia 54 2013 1036 1045
84. H. Ishiura, S. Matsuda, and M. Higashihara et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab Neurology 71 2008 1921 1923
85. L. Bataller, K.A. Kleopa, and G.F. Wu et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes J Neurol Neurosurg Psychiatry 78 2007 381 385
86. D.M. Wingerchuk, V.A. Lennon, and C.F. Lucchinetti et al. The spectrum of neuromyelitis optica Lancet Neurol 6 2007 805 815
87. F. Brilot, R.C. Dale, and R.C. Selter et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease Ann Neurol 66 2009 833 842
88. J.P. Camdessanche, N. Streichenberger, and G. Cavillon et al. Brain immunohistopathological study in a patient with anti-NMDAR encephalitis Eur J Neurol 18 2011 929 931
89. N.L. Khan, M.A. Jeffree, and C. Good et al. Histopathology of VGKC antibody-associated limbic encephalitis Neurology 72 2009 1703 1705
90. R.C. Dale, S. Pillai, and F. Brilot Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis Dev Med Child Neurol 55 2013 191 193
91. R. Shah, A. Veerapandiyan, and S. Winchester et al. Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies Pediatr Neurol 45 2011 412 416
92. A. Vincent, S.R. Irani, and B. Lang The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins Curr Opin Neurol 23 2010 144 150
93. A. McKeon, E. Martinez-Hernandez, and E. Lancaster et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype JAMA Neurol 70 2013 44 50
94. A. Boronat, J.M. Gelfand, and N. Gresa-Arribas et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels Annals of Neurology 73 2013 120 128
95. E. Lancaster, E. Martinez-Hernandez, and M.J. Titulaer et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome Neurology 77 2011 1698 1701
96. A. Mat, H. Adler, and A. Merwick et al. Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF Neurology 80 2013 1349 1350